Skip to content

The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05997251
Enrollment
66
Registered
2023-08-18
Start date
2021-03-01
Completion date
2022-03-01
Last updated
2023-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Adiponectin

Brief summary

The aim of this study is to reveal the relationship of DASH and Mediterranean diet score with anthropometric measurements and serum adiponectin level in individuals with spinal cord injury. This research was planned as a cross-sectional, case-control study. With the data to be obtained from the research, information will be obtained about the hormonal or biochemical basis of metabolic disorders such as atherosclerosis and insulin resistance that may occur in individuals with spinal cord injury in the long term. 20 individuals with Spinal Cord Injury will be included in the study, and the results of the patients will be compared with 20 healthy individuals. In order to determine the food consumption status of the patients, a 1-day food consumption record will be requested. DASH diet score and Mediterranean diet score will be calculated from dietary records. After 8 hours of fasting, 3 ml of peripheral blood will be taken for the measurement of adiponectin between 08:00 and 09:00 in the morning from the individuals in the study and control groups. Adiponectin level will be measured and its correlation with DASH diet score and Mediterranean diet score will be examined.

Interventions

OTHERKeeping a 1-day food consumption record by the patient

Checking and receiving the 1-day food consumption record recorded by the patient by the researcher

OTHERMeasurement of adiponectin level

Adiponectin level will be measured for each group

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion criteria (Study group) * Having spent at least 6 months after spinal cord injury * 1st motor neuron injury * Being between the ages of 18-65 * Giving consent to participate in the study Inclusion criteria (Control group) * Being between the ages of 18-65 * Giving consent to participate in the study

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Adiponectin levelWill be measured at inclusionAdiponectin level will be measured from peripheral blood
DASH diet scoreWill be measured at inclusion from one day dietary recordWill be measured at inclusion from one day dietary record
Mediterrenian diet scoreWill be measured at inclusion from one day dietary recordWill be measured at inclusion from one day dietary record

Secondary

MeasureTime frameDescription
LDLWill be measured at inclusionWill be measured at inclusion
Whole blood countWill be measured at inclusionWill be measured at inclusion
TGWill be measured at inclusionWill be measured at inclusion
HDLWill be measured at inclusionWill be measured at inclusion
Fasting blood glucoseWill be measured at inclusionWill be measured at inclusion
Total cholesterolWill be measured at inclusionWill be measured at inclusion

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026